Creative Planning’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Creative Planning’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-470	Closed	-$81K	–	4071
2015 Q1	$81K	Sell	470 -250	-35%	-$36.7K	﹤0.01%	1698
2014 Q4	$83K	Buy	720 +79	+12%	+$9.57K	﹤0.01%	1653
2014 Q3	$100K	Buy	641 +50	+8%	+$7.25K	﹤0.01%	1485
2014 Q2	$73K	Hold	591	–	–	﹤0.01%	1638
2014 Q1	$61K	Hold	591	–	–	﹤0.01%	1686
2013 Q4	$53K	Sell	591 -120	-17%	-$9.57K	﹤0.01%	1577
2013 Q3	$48K	Buy	711 +305	+75%	+$21K	﹤0.01%	1542
2013 Q2	$27K	Buy	+406	New	+$23.2K	﹤0.01%	1755

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Creative Planning's SLXP Position: Q2 2015 in Review

Creative Planning sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 470 shares — an estimated $81K sold.

Creative Planning first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $100K in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Creative Planning reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Creative Planning sold 470 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $81K.
Creative Planning first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Creative Planning's SALIX PHARMACEUTICALS LTD DEL position peaked at $100K in Q3 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Creative Planning's 13F filing for Q2 2015, filed 9 Jul 2015.